Interleukin-1␤ (IL-1␤) is involved in mood alterations associated with inflammatory illnesses and with stress. The synaptic basis of IL-1␤-induced emotional disturbances is still unknown. To address the possible involvement of the endocannabinoid system in IL-1␤-induced anxiety, we performed behavioral and neurophysiological studies in mice exposed to stress or to intracerebroventricular injections of this inflammatory cytokine or of its antagonist. We found that a single intracerebroventricular injection of IL-1␤ caused anxiety in mice, and abrogated the sensitivity of cannabinoid CB1 receptors (CB1Rs) controlling GABA synapses in the striatum. Identical behavioral and synaptic results were obtained following social defeat stress, and intracerebroventricular injection of IL-1 receptor antagonist reverted both effects. IL-1␤-mediated inhibition of CB1R function was secondary to altered cholesterol composition within membrane lipid rafts, and required intact function of the transient receptor potential vanilloid 1 (TRPV1) channel, another element of the endocannabinoid system. Membrane lipid raft disruption and inhibition of cholesterol synthesis, in fact, abrogated IL-1␤-CB1R coupling, and TRPV1Ϫ/Ϫ mice were indeed insensitive to the synaptic and behavioral effects of both IL-1␤ and stress. On the other hand, cholesterol enrichment of striatal slices mimicked the synaptic effects of IL-1␤ on CB1Rs only in control mice, while the same treatment was ineffective in slices prepared from TRPV1Ϫ/Ϫ mice. The present investigation identifies a previously unrecognized interaction between a major proinflammatory cytokine and the endocannabinoid system in the pathophysiology of anxiety.
Introduction
The role of inflammatory cytokines in the pathophysiology of mood disturbances is increasingly recognized (Dantzer et al., 2008; Miller et al., 2009 ). For example, high levels of proinflammatory cytokines have been found in peripheral blood and in CSF of depressed patients (Zorrilla et al., 2001) , and blockade of cytokine signaling is associated with relevant mood-enhancing effects in humans (Tyring et al., 2006) . In addition, systemic administration of lipopolysaccharide, which induces the expression of interleukin-1␤ (IL-1␤) and of other inflammatory cytokines in the brain (van Dam et al., 1992; Breder et al., 1994; Layé et al., 1994) , causes depression and anxiety in healthy subjects (Reichenberg et al., 2001; Miller at al., 2009 ). In line with this, the clinical use of IL-2, interferon-␣, or interferon-␤ in chronic diseases has been convincingly associated with the development of anxious depression and suicidal ideation (Capuron et al., 2000; Goeb et al., 2006; Dantzer et al., 2008) .
Also, ample data show that proinflammatory cytokines in rodents are involved in mood regulation and, in fact, systemic or central administration of the major inflammatory cytokine IL-1␤ causes behavioral manifestations closely resembling anxiousdepressive symptoms in humans, including anhedonia, reduced exploratory behaviors, social withdrawal, fatigue, and sleep disturbances (Dantzer et al., 2008; Miller et al., 2009) . The mechanism by which inflammation exerts its mood-controlling effects is largely undetermined, although alterations of serotonin metabolism (Moreau et al., 2005; Zhu et al., 2006; Snyder, 2011) and of the hypotalamus-pituitary-adrenal (HPA) axis have been implicated (Pace et al., 2007) .
The endocannabinoid system (ECS) plays a fundamental role in emotional disorders, and magnification of endocannabinoid signaling has antidepressant and antianxiety actions in humans (Hariri et al., 2009) ). Conversely, blockade of type-1 cannabinoid receptors (CB1Rs) has the opposite effect in humans (Hill and Gorzalka, 2009; Topol et al., 2010) and in rodents (Beyer et al., 2010; De Chiara et al., 2010a) . These data suggest an interaction between inflammatory cytokines and the ECS in emotional control, but this possibility has never been investigated so far.
Thus, the present study, by exploring the possible involvement of the ECS in this effect, was specifically designed to clarify the synaptic substrate of IL-1␤-induced anxiety. We focused on CB1Rs controlling GABA synapses (CB1Rs (GABA) ) in the striatum because this brain area is emerging as a key structure in mood regulation in humans (Reiman et al., 1989; Yoo et al., 2005; Mathew and Ho, 2006) and in rodents (Nestler and Carlezon, 2006; Favilla et al., 2008; Zhang et al., 2008; Steiner et al., 2010) . In addition, anxious-depressive behavior is associated with reduced sensitivity of striatal CB1Rs (GABA) , whose activity is rescued by mood-enhancing and antianxiety pharmacological and environmental manipulations Hill and Gorzalka, 2009; De Chiara et al., 2010a,b) .
Materials and Methods
Mice. Male C57BL/6 mice (8 -10 weeks old) were used. Mice lacking transient receptor potential vanilloid 1 (TRPV1) channels (TRPV1Ϫ/Ϫ, Jackson Laboratory) were also used along with their matched wild-type (WT) counterparts ). All efforts were made to minimize animal suffering and to reduce the number of mice used, in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC). All animals were housed, four per cage, on a 12 h light/dark cycle with lights on at 6 A.M.
In vivo treatments. IL-1␤ (1.0 g/kg) or IL-1␤ receptor antagonist (IL-1ra, 1.25 mg/kg) (both dissolved in PBS; both from R&D Systems) were administered in vivo by a single intracerebroventricular injection (0.2 g/l saline) under stereotaxic coordinates (from bregma: antero-posterior, 0 mm; lateral, 0.8 mm; depth, 2.4 mm from the skull) and general anesthesia with 2,2,2-tribromoethanol (10 mg/ml; 1/27 of body weight). In other experiments, a single dose of 5-iodoresiniferatoxin (I-RTX) (0.75 mg/kg dissolved in dimethylsulfoxide (DMSO); Tocris Bioscience) was injected intraperitoneally in stressed mice. Animals receiving intracerebroventricular or intraperitoneal injections of the appropriate volume of vehicle were used as controls and, in all cases, behavioral or electrophysiological experiments were performed 24 h after the intracerebroventricular or intraperitoneal injections.
Psychoemotional stress. Social defeat stress (SDS) was induced as already described De Chiara et al., 2010a) . Briefly, individual mice were subjected to daily bouts for 10 min with an aggressive CD1 resident mouse, followed by 3 h protected sensory contact with their aggressor. Mice were exposed to a different aggressor each day for 3 d.
Behavior. To measure anxiety, the open field test (OFT) and the elevated plus maze (EPM) were used. The two tests were administered 2 h apart in random sequence in each group of animals and in their appropriate controls (8 mice per group). In stressed mice, intracerebroventricular IL-1ra or intraperitoneal I-RTX were administered immediately after the last session of the three consecutive daily sessions of aggression. Mice underwent the behavioral analysis 24 h after the injections of IL-1␤, IL-1ra, I-RTX, or the appropriate vehicles.
The OFT paradigm assesses motor activity of animals in an averse, stressful environment. This protocol was performed as previously reported De Chiara et al., 2010a) . Briefly, mice were placed into the center of a clear Plexiglas arena (25 ϫ 35 ϫ 20 cm), where they were allowed to explore for 30 min. Overhead incandescent light bulbs provided a 600 lux illumination inside the test chamber. Activities in the central zone, including the number of entries, the distance traveled, and total time spent in the central zone, were measured using a video tracking system (Videotrack, Viewpoint). Center distance was divided by the total distance to obtain a center/total-distance ratio used as an index of anxiety-related behavior. The total distance traveled was also extracted to provide a measure of locomotor activity, which is not confounded by any changes in anxiety.
The EPM represents one of the most widely used tests for assessing anxiety in rodents (Lister, 1987) . Each mouse was placed in the center of the maze with its nose in a closed arm. The time spent in the open arms and in the closed arms of the maze was recorded as measure of anxious state. The time spent in each compartment was expressed as percentage of the total 5 min test time. The entry with all four feet into one arm was defined as an arm entry. At the end of each trial, the arena of the OFT and the maze were wiped clean.
Electrophysiology. Whole-cell patch-clamp recordings from single striatal neurons in corticostriatal coronal slices (200 m) were performed as previously described Hill and Gorzalka, 2009; De Chiara et al., 2010a,b) . To detect GABA A -mediated spontaneous IPSCs (sIPSCs), intraelectrode solution had the following composition (in mM): 110 CsCl, 30 K ϩ -gluconate, 1.1 EGTA, 10 HEPES, 0.1 CaCl 2 , 4 Mg-ATP, 0.3 Na-GTP. MK-801 (30 M) and CNQX (10 M) were added to the external solution to block, respectively, NMDA and non-NMDA glutamate receptors.
The detection threshold of sIPSCs was set at twice the baseline noise. The fact that no false events would be identified was confirmed by visual inspection for each experiment. Offline analysis was performed on spontaneous synaptic events recorded during fixed time epochs (5-10 samplings of 2-3 min each, recorded every 2-3 min) for a total of 10 -30 min analysis for each recorded neuron, depending on the length of the experiment.
Drugs used for the electrophysiological experiments were first dissolved in DMSO (HU210) or water, then in the bathing artificial CSF (ACSF) to the desired final concentration. The concentrations of the various drugs were chosen according to previous in vitro studies on corticostriatal brain slices De Chiara et al., 2010b) and were as follows: 3 M baclofen, 10 M CNQX, 1 M HU210, 30 M MK-801 (Tocris Bioscience); 30 ng/ml IL-1␤ (R&D Systems). In some experiments, methyl-␤-cyclodextrin (MCD, 5 mM, first dissolved in water, Sigma-Aldrich) was applied for 30 min in control or IL-1␤-treated slices . Some corticostriatal slices were also incubated with cholesterol-loaded MCD (5 mM), prepared as reported (Bari et al., 2005) , for 30 min before the application of HU210 (10 min). In other experiments, striatal slices were incubated with mevestatin (10 M, first dissolved in ethanol; Tocris Bioscience) or with IL-1␤ plus mevestatin for 1 h. In the experiments with drugs dissolved in DMSO or ethanol, control samplings were obtained during application of identical volumes of DMSO or ethanol in the ACSF.
Binding experiments. Samples of mouse spinal cord or striatum were resuspended in 2 mM Tris-EDTA, 320 mM sucrose, and 5 mM MgCl 2 , pH 7.4, and then homogenized in a Potter homogenizer and centrifuged as reported . The resulting pellet was resuspended in assay buffer (50 mM Tris-HCl, 2 mM Tris-EDTA, 3 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride, pH 7.4) to a protein concentration of 1 mg/ml. The membrane preparations were divided into aliquots that were stored at Ϫ80°C for no longer than 1 week .
Membrane fractions (100 g of protein/test) were used with the TRPV1 agonist [
3 H]resinferatoxin ([ 3 H]RTX, 500 pM), and the binding was evaluated by rapid filtration assays. Unspecific binding was determined in the presence of the cold agonist RTX or the selective antagonist I-RTX (both used at 1 M), as reported . RTX was purchased from Sigma-Aldrich, [
3 H]RTX (43 Ci/mmol) was from PerkinElmer Life Sciences, and I-RTX was from Tocris Bioscience.
Statistical analysis. The analyses were performed on a per-animal basis, and throughout the text "n" refers to the number of mice used. Eight mice were used for each behavioral experiment, and 5-8 mice were used for a single electrophysiological experiment. Electrophysiological results from neurons recorded from the same animal were treated as a separate sample and averaged before calculating statistics. One to six neurons per animal were recorded. One or two animals per day were used for the electrophysiological experiment. For data presented as the mean Ϯ SEM, statistical analysis between two groups was performed using a paired or unpaired Student's t test or Wilcoxon's test. Multiple comparisons were analyzed by one-way ANOVA followed by Tukey's HSD. The signifi-cance level of the results was established at p Ͻ 0.05. Degrees of freedom for significant p values were shown.
Results

Central IL-1␤ is involved in anxiety
The emotional status of mice treated with IL-1␤ was tested 24 h after a single intracerebroventricular injection of this cytokine (n ϭ 8) or of vehicle (n ϭ 8) at the OFT and the EPM. At the OFT, the activity in the center of arena and the center/ total-distance ratio can be used as an index of anxiety-related responses, as anxiety reduces the time spent in the center of the arena (De Chiara et al., 2010a; At the EPM, mice receiving intracerebroventricular IL-1 also showed increased anxiety by spending more time in the closed arms than in the open arms compared with vehicle-injected animals (percentage of time spent in open arms: 14.5 Ϯ 1.0% vs 41.9 Ϯ 2.1%, t (14) ϭ 11.77, p Ͻ 0.01; percentage of time spent in closed arms: 69.8 Ϯ 2.1% vs 38.3 Ϯ 3.7%, t (14) ϭ 7.46, p Ͻ 0.01). The involvement of IL-1␤ signaling was also explored in the anxious state induced by SDS De Chiara et al., 2010a) . Intracerebroventricular administration of IL-1ra immediately after the last session of 3 consecutive days of SDS significantly interfered with the development of anxiety evaluated 24 h later (OFT: center time: F (3,28) ϭ 20.3, p Ͻ 0.0001; center entry count: F (3,28) ϭ 8.0, p ϭ 0.0005; center/total-distance ratio: F (3,28) ϭ 7.8, p Ͻ 0.001; EPM: percentage of time spent in open arms: F (3,28) ϭ 10.2, p ϭ 0.0001; percentage of time spent in closed arms: F (3,28) ϭ 24.3, p Ͻ 0.0001). In fact, intracerebroventricular IL-1ra (n ϭ 8) was able to block the development of the anxious state compared with stressed mice (n ϭ 8) treated with intracerebroventricular vehicle (OFT: center time: p Ͻ 0.001; center entry count: p Ͻ 0.01; center/total-distance ratio: p Ͻ 0.05; EPM: p Ͻ 0.001 for both parameters). Of note, intracerebroventricular IL-1ra had negligible effects at both the OFT and the EPM in nonstressed mice ( p Ͼ 0.05 for all parameters, compared with nonstressed mice treated with intracerebroventricular vehicle; n ϭ 8 for both groups) (Fig. 1A,B) .
IL-1␤ blocks striatal CB1Rs (GABA)
Loss of sensitivity of CB1Rs controlling GABA synapses in the striatum has been shown previously to represent a synaptic counterpart of the anxious state induced by SDS in mice De Chiara et al., 2010a,b) . Thus, we wondered whether IL-1␤ could affect the sensitivity of these receptors and in turn cause anxiety. The synaptic response to the CB1R agonist HU210 was therefore measured in brain slices from mice treated with intracerebroventricular vehicle or IL-1␤ (n ϭ 5 for both groups) 24 h after the treatment. Intracerebroventricular IL-1␤ was able to fully block the sensitivity of CB1Rs (GABA) ( p Ͼ 0.05 compared with pre-HU210 values), while HU210 caused the expected reduction of sIPSC frequency in mice receiving intracerebroventricular vehicle (t (4) ϭ 4.31, p Ͻ 0.01) ( Fig. 2A ). IL-1␤ was able to block CB1Rs (GABA) even when applied in the bathing solution of corticostriatal slices of naive mice (n ϭ 12, p Ͼ 0.05 compared with pre-HU210) (Fig. 2B) , indicating that IL-1␤'s effect on these receptors is mediated centrally and does not follow, for example, the activation of the HPA axis in intact mice treated with intracerebroventricular IL-1␤ (Pace et al., 2007) . Circulating corticosterone secondary to the activation of the HPA axis, in fact, is also known to penetrate the brain, and to cause loss of CB1R (GABA) sensitivity within the striatum .
The involvement of CB1Rs (GABA) in the mood-regulating effect of IL-1␤ was also explored in stressed mice treated with intracerebroventricular IL-1ra. As reported De Chiara et al., 2010a,b) , the anxious behavior of mice exposed to SDS only receiving intracerebroventricular vehicle was associated with abrogated sensitivity of GABAergic sIPSCs to HU210 (n ϭ 7, p Ͼ 0.05 compared with pre-HU210) (Fig. 2C) . Blockade of IL-1␤ signaling with intracerebroventricular IL-1ra in mice exposed to SDS was conversely associated with normal response to the pharmacological stimulation of CB1Rs (GABA) (n ϭ 6, t (5) ϭ 4.13, p Ͻ 0.01 compared with pre-HU210). Of note, intracerebroventricular IL-1ra did not potentiate HU210 responses in nonstressed mice (n ϭ 8, p Ͼ 0.05 compared to HU210 responses in nonstressed mice receiving i.c.v. vehicle or IL-1ra) (Fig. 2C) , which is consistent with behavioral results showing that this inhibitor does not produce antianxiety effects in nonstressed mice. These findings are also in keeping with previous results showing that potentiation of HU210 responses is only seen in association with pharmacological and environmental manipulations causing antianxiety effects in nonstressed mice (De Chiara et al., 2010a) .
GABA B receptors are insensitive to IL-1␤
Along with CB1Rs (GABA) , striatal GABA synapses are controlled by other receptor subtypes inhibiting transmitter release. Thus, we investigated whether the effect of IL-1␤ on sIPSCs was specific for CB1Rs (GABA) or also involved GABA B receptors. As reported (De Chiara et al., 2010b) , application of the GABA B receptor agonist baclofen (n ϭ 6) significantly (t (5) ϭ 7.76, p Ͻ 0.01) reduced striatal sIPSC frequency in control slices. In slices incubated with IL-1␤, the inhibitory effect of baclofen was similar to that seen under control conditions (n ϭ 7, p Ͼ 0.05, compared with baclofen in control slices) (Fig. 3A) .
Involvement of cholesterol metabolism in IL-1␤-mediated suppression of CB1Rs (GABA)
Striatal CB1Rs (GABA) function within lipid rafts, which are subdomains of the plasma membranes that contain high concentrations of cholesterol (Lister, 1987; De Chiara et al., 2010b) . IL-1␤ has been already demonstrated to increase cholesterol intracellular accumulation (Zhang et al., 2011) , raising the possibility that altered lipid composition in rafts might mediate the effects of IL-1␤ on CB1Rs (GABA) . Thus, we first investigated whether MCD, which causes a significant depletion of cholesterol in striatal slices , was able to reverse the effects of IL-1␤ on CB1R (GABA) sensitivity. As already reported De Chiara et al., 2010b) , preincubation of striatal slices with MCD did not increase per se the sensitivity of CB1Rs (GABA) to HU210 (n ϭ 5, p Ͼ 0.05 compared with HU210 in control slices). MCD, however, was able to rescue the effect of HU210 on sIPSC frequency after IL-1␤ administration in vitro (n ϭ 6, t (5) ϭ 4.89, p Ͻ 0.05 compared with pre-HU210) (Fig. 3B) .
We also explored the effect of mevastatin, an inhibitor of cholesterol synthesis able to block cholesterol accumulation in lipid Figure 2 . IL-1␤ blocks CB1Rs controlling GABA synapses in the striatum. A, B, Graphs show that the depressant effect of the CB1 receptor agonist HU210 on sIPSC frequency was abolished by IL-1␤ intracerebroventricular injection (A, n ϭ 5 for both experimental groups) or by incubation of striatal slices with IL-1␤ (B, n ϭ 12). C, HU210-induced reduction of sIPSC frequency was lost in stressed mice (n ϭ 7), but it was normal in stressed mice treated with intracerebroventricular injection of IL-1ra (n ϭ 6), and in nonstressed mice treated with intracerebroventricular IL-1ra (n ϭ 8). The electrophysiological traces on the right are examples of voltage-clamp recordings showing the loss of sIPSC frequency reduction induced by HU210 in a neuron from IL-1␤ intracerebroventricular-treated mice, and the recovery of the effects of HU210 induced by intracerebroventricular IL-1ra in another neuron from a stressed mouse.
rafts (Suzuki et al., 2007; De Chiara et al., 2010b) . As with MCD, mevastatin did not affect the sensitivity of CB1Rs (GABA) to HU210 (n ϭ 6, p Ͼ 0.05 compared with HU210 in control slices), but significantly interfered with IL-1␤-induced suppression of HU210 effects (n ϭ 6, t (5) ϭ 5.81, p Ͻ 0.05 compared with pre-HU210) (Fig. 3C) .
Involvement of TRPV1 channels in the synaptic effects of IL-1␤
We then tried to detail the mechanism responsible for IL-1␤-mediated inhibition of CB1R (GABA) function. We have already found that stimulation of TRPV1 channels inhibits the signaling at striatal CB1Rs (GABA) , and we postulated, therefore, that these channels could also play a role in the effect of IL-1␤ on these receptors. IL-1␤, applied intracerebroventricularly (n ϭ 6) or in the slice bathing solution (n ϭ 6), failed to block the sensitivity of CB1Rs (GABA) to HU210 in mice lacking TRPV1 channels (i.c.v. IL-1␤: t (5) ϭ 6.09, p Ͻ 0.01 compared with pre-HU210 values; IL-1␤ applied in slice: t (5) ϭ 8.31, p Ͻ 0.01 compared with pre-HU210 values), indicating that these channels are essential for the synaptic effects of IL-1␤ (Fig. 4 A, B) . HU210 responses were not potentiated in slices from TRPV1Ϫ/Ϫ mice either in the absence (n ϭ 6) or in the presence (n ϭ 6) of IL-1␤ ( p Ͼ 0.05 compared with HU210 responses in WT mice) (Fig. 4B) .
The effect of HU210 on sIPSC frequency was also normal in TRPV1Ϫ/Ϫ mice exposed to the SDS protocol (n ϭ 5) (t (8) ϭ 3.03, p Ͻ 0.01 compared with stressed WT mice), and in WT mice treated at the end of the SDS protocol with a single intraperitoneal injection of I-RTX (n ϭ 6), a selective blocker of TRPV1 channels (t (10) ϭ 4.34, p Ͻ 0.01, compared with stressed mice receiving i.p. vehicle) (Fig. 4C,D) . These data indicate, therefore, the involvement of TRPV1 channels in IL-1␤ signaling activated by stress. TRPV1 channels are activated by a variety of chemical and physical stimuli, which include vanilloid compounds, voltage, heat, protons, and lipid molecules, such as endocannabinoids and eicosanoids (Starowicz et al., 2007 (Starowicz et al., , 2008 . The promiscuity of these receptor channels and the results above led us to postulate that IL-1␤ could also bind to and activate TRPV1 channels. However, the binding of the TRPV1 agonist [ 3 H]RTX was not affected by the presence of IL-1␤ in either striatum or spinal cord ( p Ͼ 0.05, n ϭ 3 in both cases), ruling out the possibility of a direct action of IL-1␤ on TRPV1 channels (Fig. 4 E, F ) .
Cholesterol-loaded MCD blocks CB1Rs (GABA) in WT but not in TRPV1؊/؊ mice
The results above show that both membrane cholesterol and TRPV1 channels are essential for the synaptic effect of IL-1␤, but do not clarify whether cholesterol is important for TRPV1 channels to exert their control on striatal CB1R (GABA) function. We addressed this possibility by measuring the effects of membrane cholesterol enrichment in control and TRPV1Ϫ/Ϫ mice. Membrane cholesterol enrichment with cholesterol-loaded MCD fully blocked the sensitivity of CB1Rs (GABA) to HU210, thereby mimicking the effects of IL-1␤ on striatal sIPSCs (n ϭ 7, p Ͼ 0.05 compared with pre-HU210 values). In slices from TRPV1Ϫ/Ϫ Figure 3 . Involvement of cholesterol metabolism in the IL-1␤-mediated suppression of striatal CB1Rs (GABA) . A, IL-1␤ failed to affect the depressant effect of GABA B receptor agonist baclofen on sIPSC frequency in neurons from striatal slices (control condition: n ϭ 6; IL-1␤: n ϭ 7). B, MCD, which causes a significant depletion of cholesterol in striatal slices, was able to rescue the effect of HU210 on sIPSC frequency after IL-1␤ administration in vitro (control condition: n ϭ 5; MCD: n ϭ 6). C, Similarly, pharmacological inhibition of cholesterol synthesis with mevastatin also prevented IL-1␤-induced suppression of HU210 effects (control condition: n ϭ 6; mevastatin: n ϭ 6). The electrophysiological traces on the right are examples of voltage-clamp recordings.
mice, however, cholesterol-loaded MCD did not alter HU210 effects (n ϭ 8, p Ͻ 0.01 compared with pre-HU210), suggesting that IL-1␤-induced membrane cholesterol increase requires intact TRPV1 channel function to suppress the activity of CB1Rs (GABA) (Fig.  5) . In this respect, it seems of interest that a cholesterol-binding site has been recently described in TRPV1 channels (Picazo-Juárez et al., 2011), suggesting that their function might depend on membrane cholesterol content.
Involvement of TRPV1 channels in the behavioral effects of IL-1␤
TRPV1 channels played a crucial role also in the behavioral effects of IL-1␤. Intracerebroventricular IL-1␤, in fact, failed to provoke anxiety in TRPV1Ϫ/Ϫ mice, because both OFT and EPM evaluations gave comparable results in TRPV1Ϫ/Ϫ mice receiving intracerebroventricular IL-1␤ (n ϭ 8) or intracerebroventricular vehicle (n ϭ 8) ( p Ͼ 0.05 for all parameters), and in the corresponding WT animals injected with vehicle ( Fig. 6 A, B) . Also locomotor activity, measured as total distance traveled at the OFT, did not differ significantly between groups (F ϭ 0.92, p ϭ 0.44; data not shown). In line with the synaptic data, TRPV1Ϫ/Ϫ mice were also insensitive to the behavioral consequences of stress, because the SDS protocol applied to these animals (n ϭ 8) did not cause anxiety at the OFT and at the EPM, compared with WT mice ( p Ͼ 0.05 for all parameters) (Fig. 6C,D) .
Discussion
The present investigation identifies a previously unrecognized interaction between a major proinflammatory cytokine and endocannabinoid-binding receptors, and provides for the first time a plausible synaptic mechanism at the basis of anxiety associated with the inflammatory response. It also points to central IL-1␤ signaling as a critical player in anxiety secondary to environmental stress, confirming a wider role of this cytokine in emotional disorders (Goshen et al., 2008; Koo and Duman, 2009; Norman et al., 2010) . In fact, while mice exposed to environmental (Starowicz et al., 2008) or physical (Norman et al., 2010) stressful conditions display anxious-depressive-like symptoms, their brains increase expression of IL-1. Instead, studies involving genetic deletion of IL-1 receptor (Goshen et al., 2008) and those involving systemic (Norman et al., 2010) or central administration of IL-1ra (present study) using mice that were not exposed to stressful paradigms, found that these mice spent more time than control mice in the open arms of the EPM. Transgenic mice overexpressing IL-1ra likewise spent more time than control mice in the open arms of the EPM (Oprica et al., 2005) . Most notably, higher mRNA and protein expression of IL-1␤ has also been described in postmortem brain specimens of individuals with idiopathic bipolar disorder (Rao et al., 2010) .
Injection of IL-1ra only after the final day of SDS was sufficient to interfere with the behavioral and synaptic consequences Figure 4 . Involvement of TRPV1 channels in IL-1␤-mediated suppression of striatal CB1Rs (GABA) .A,B, IL-1␤, applied intracerebroventricularly (A, n ϭ 6) or in the slice bathing solution (B, n ϭ 6), failed to block the sensitivity of CB1Rs (GABA) to HU210 in mice lacking TRPV1 channels. C, D, SDS failed to block the sensitivity of CB1Rs (GABA) to HU210 in mice lacking TRPV1 channels (C, n ϭ 5) or in WT mice treated with a single intraperitoneal injection of I-RTX, a blocker of TRPV1 channels (D, n ϭ 6). E, F, Histograms show that the binding of TRPV1 agonist[ of stress evaluated 24 h later. This evidence might suggest that SDS-induced neuroadaptive changes need time to appear or that they are reversible. We have previously demonstrated that 1 d of SDS causes only a partial suppression of the sensitivity of CB1R (GABA) to HU210, which is instead complete after 3 d . Furthermore, we have also described the spontaneous rescue of CB1R (GABA) function 3 d after the last session of stress , and the ability of some environmental (running wheel, sucrose drinking) or pharmacological manipulations (cocaine), known to activate the dopamine-dependent reward pathway, to accelerate the full recovery of CB1R (GABA) sensitivity and of the anxious behavior De Chiara et al., 2010a) . Thus, the data with IL-1ra after SDS are in line with these previous results, and might indicate that this antagonist mimics the effect of cocaine, running wheel, or sucrose because it activates the reward system inhibited by IL-1␤ signaling triggered by stress. In this respect, a bulk of existing literature has already demonstrated the negative interference of IL-1␤ with nigrostriatal dopamine system (Barnum et al., 2008; Chung et al., 2010; Long-Smith et al., 2010) .
In the CNS, several G-protein-coupled receptors (GPCRs), including CB1R (GABA) De Chiara et al., 2010b) , segregate within lipid rafts, and cholesterol is essential for their function by controlling the fluidity of membranes, thus affecting the freedom of movements of lipid raft-associated proteins, as well as the ability of vesicles to deform and fuse with plasma membranes (Suzuki et al., 2007; Maccarrone et al., 2011) . In addition, cholesterol can modulate the activity of GPCRs by promoting receptor dimerization and hence reducing agonist binding . We have demonstrated that IL-1␤ controls striatal CB1R (GABA) activity by regulating cholesterol metabolism, extending for the first time to neuronal elements the described effects of IL-1␤ on cholesterol synthesis in other cell types (Zhang et al., 2011) .
A further novel finding of this study is the evidence that IL-1␤ is an indirect regulator of another element of the ECS, namely TRPV1 channels, and that these channels exert a permissive role in the IL-1␤-CB1R interaction, likely because they are sensitive to cholesterol content within lipid rafts. Accordingly, we have found that cholesterol enrichment of striatal slices mimicked the synaptic effects of IL-1␤ on CB1Rs (GABA) only in control mice, while the same treatment was ineffective in slices prepared from TRPV1Ϫ/Ϫ mice. These findings indicate therefore that TRPV1 effects on CB1R function are regulated by membrane cholesterol content, and are consistent with recent evidence demonstrating a cholesterol-binding site in TRPV1 channels (Picazo-Juárez et al., 2011) .
To support the role of TRPV1 channels in CB1R function and mood control, previous studies have already reported that pharmacological stimulation of TRPV1 channels with capsaicin interferes with the synthesis of the endocannabinoid 2-arachidonoyl-glycerol and with striatal CB1R (GABA) The mechanism by which stimulation of TRPV1 channels dampens striatal CB1R (GABA) activation by its endogenous agonist has been described in a previous report, and involves a complex intracellular pathway that also includes the regulation of gluthatione metabolism and, hence, of endocannabinoid tone . Meanwhile, other receptor subtypes also involved in the presynaptic control of striatal GABA transmission do not seem to be under the control of IL-1␤ because this proinflammatory failed to affect the inhibition of sIPSC frequency caused by the GABAB receptor agonist baclofen.
The involvement of striatal neuron activity in the control of anxiety-related behavior in humans (Yoo et al., 2005; Mathew and Ho, 2006) and in rodents (Favilla et al., 2008) has been recently emphasized. In this respect, GABA-mediated inhibition of striatal neuron activity possibly disrupts a circuitry normally limiting fearful or anxiety-related behaviors (Rogan et al., 2005) , and enhancement of cAMP signaling in the striatum has been associated with increased anxious-depressive behavior in mice (Favilla et al., 2008; Zhang et al., 2008) . This information confirms the relevance of our findings for the pathophysiology of emotional disorders. CB1Rs, in fact, reduce transmitter release by inhibiting cAMP levels in presynaptic nerve terminals (Howlett et al., 2004) , implying that IL-1␤-mediated inhibition of CB1R sensitivity results in enhanced cAMP signaling in neuronal elements. Of note, the involvement of striatal CB1Rs (GABA) in emotional control has been defined in previous studies showing that the anxious phenotype of mice exposed to SDS is associated with loss of sensitivity of these receptors in the striatum , and that potentially rewarding experiences contrast the behavioral consequences of stress by enhancing CB1R (GABA) function (De Chiara et al., 2010a,b) . In addition, intrastriatal selective infusion of BDNF elicits a depressive behavior in mice (Eisch et al., 2003) , and the anxious behavior induced by the SDS protocol used in the present study is abolished by blockade of BDNF signaling in this brain area (Berton et al., 2006) . These data therefore confirm the crucial role of the striatum in mood regulation, and also emphasize the relevance of striatal CB1R (GABA) within lipid raft in emotional control, as BDNF has been found to block these receptors through a mechanism involving cholesterol metabolism (De Chiara et al., 2010b) .
Among the various elements of the ECS, not only CB1Rs (Hill and Gorzalka, 2009; Beyer et al., 2010; De Chiara et al., 2010a; Topol et al., 2010) , but also TRPV1 channels have been identified as possible players in mood regulation. In particular, pharmacological stimulation of TRPV1 channels generates anxiety in rodents (Campos and Guimarães, 2009 ) and limits the antianxiety effects of simultaneous activation of CB1Rs (Micale et al., 2009 ). In addition, TRPV1Ϫ/Ϫ mice exhibit reduced anxiety evaluated at the light/dark test and at the EPM compared with their WT littermates (Marsch et al., 2007) , although our results showing similar behavioral responses at the OFT and the EPM in TRPV1Ϫ/Ϫ and in WT mice receiving intracerebroventricular injections of saline indicate a certain sensitivity of these mutants to the stress inherent in the surgical procedure. The synaptic basis of the antianxiety effect of pharmacological or genetic inactivation of TRPV1 channels was not clarified in those previous studies, and likely lies on the preservation of CB1R (GABA) function, as our results seem to indicate.
Anxiety and depression are frequent and severe psychiatric conditions that occur in the absence or in the presence of concomitant medical or neurological conditions. Largely because the neurobiological bases of mood disorders are incompletely understood, only a limited proportion of these patients have a satisfactory response to current medications. Targeting IL-1␤-CB1R interaction might represent a novel route for the treatment of anxiety associated or not with systemic or neuroinflammatory diseases in humans.
